文献速递腹部MR

MRI偶然检出胰腺囊肿的相关下游费用

Downstream Costs Associated With Incidental Pancreatic Cysts Detected at MRI.
PubMed 文献 · AJR Am J Roentgenol · 2018-10-09

本研究评估MRI偶然检出胰腺囊肿的下游费用。200例患者中,平均每例囊肿下游费用为460美元(有任何随访检查者为872美元),9例出现临床相关结局。当开单医师相对于放射科医师建议过度管理时费用更高(842美元 vs 依从631美元 vs 管理不足252美元)。

要点

  • MRI偶然检出胰腺囊肿平均下游费用为每例460美元,有任何随访检查者为872美元。
  • 开单医师相对于放射科医师建议过度管理时费用(842美元)高于依从(631美元)或管理不足(252美元)。
  • 放射科医师是否建议随访检查及建议是否依从ACR指南对费用无显著影响。

核心结论

  • 研究结果提示有针对性的教育努力、协作伙伴关系及其他举措可促进对放射科医师建议的更大依从性,包括关键检查结果通知系统、电子健康系统内的自动提醒以及在放射学报告中不建议随访检查时使用更强措辞。

研究设计与样本

  • 研究纳入200例MRI偶然检出胰腺囊肿的患者,从电子病历中识别下游事件(影像、门诊就诊、超声内镜引导下细针穿刺或化疗),放射科医师建议和开单医师管理相对于ACR偶然发现委员会建议进行分类,费用使用全国Medicare费率并以3%年贴现率估算,计算平均费用。

诊断标准与关键数值

  • 9例患者在随访期间出现临床相关结局(囊肿增大、新发囊肿或发生胰腺癌);有临床相关结局者的每例囊肿下游费用为1364美元。相对于放射科医师建议,开单医师过度管理时费用为842美元,依从时为631美元,管理不足时为252美元;相对于ACR偶然发现委员会建议,开单医师管理不足时费用为252美元,依从时为811美元,过度管理时为845美元。放射科医师是否建议随访检查的费用范围为317-491美元;放射科医师建议相对于ACR建议为依从、管理不足或过度管理的费用范围为344-528美元,无显著差异。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to assess downstream costs associated with pancreatic cysts incidentally detected at MRI.

MATERIALS AND METHODS: Two hundred patients with an incidental pancreatic cyst detected at MRI were identified. Downstream events (imaging, office visits, endoscopic ultrasound-guided fine-needle aspiration, or chemotherapy) were identified from the electronic medical record. Radiologists' recommendations and ordering physician management were classified relative to the American College of Radiology (ACR) incidental findings committee recommendations. Costs for the downstream events were estimated using national Medicare rates and a 3% annual discount rate. Mean costs were computed.

RESULTS: Estimated downstream costs averaged $460 per cyst ($872 per cyst with any follow-up testing). Nine patients had a clinically relevant outcome during follow-up (increase in cyst size, development of new cyst, or development of pancreatic cancer). Downstream cost per cyst with a clinically relevant outcome was $1364. Costs were greater when ordering physicians overmanaged ($842) versus when they were adherent ($631) or undermanaged ($252) relative to radiologist recommendation. Although costs were $252 when ordering physicians undermanaged relative to ACR incidental findings committee recommendations, costs were similar when ordering physicians were adherent ($811) or overmanaged ($845) relative to ACR incidental findings committee recommendations. Costs did not vary significantly according to whether radiologists recommended follow-up testing ($317-$491) or whether radiologist recommendations were adherent, undermanaged, or overmanaged relative to ACR incidental findings committee recommendations ($344-$528).

CONCLUSION: The findings suggest a role for targeted educational efforts, collaborative partnerships, and other initiatives to foster greater adherence to radiologist recommendations, including critical test results notification systems, automated reminders within electronic health systems, and stronger language within radiology reports when no follow-up testing is recommended.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Rosenkrantz AB, Xue X, Gyftopoulos S, et al. Downstream Costs Associated With Incidental Pancreatic Cysts Detected at MRI. AJR Am J Roentgenol. 2018. PMID: 30300007. doi:10.2214/AJR.18.19885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。